↓ Skip to main content

Parasite Carbohydrate Vaccines

Overview of attention for article published in Frontiers in Cellular and Infection Microbiology, June 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
7 X users
facebook
1 Facebook page
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
113 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Parasite Carbohydrate Vaccines
Published in
Frontiers in Cellular and Infection Microbiology, June 2017
DOI 10.3389/fcimb.2017.00248
Pubmed ID
Authors

Jonnel A. Jaurigue, Peter H. Seeberger

Abstract

Vaccination is an efficient means of combating infectious disease burden globally. However, routine vaccines for the world's major human parasitic diseases do not yet exist. Vaccines based on carbohydrate antigens are a viable option for parasite vaccine development, given the proven success of carbohydrate vaccines to combat bacterial infections. We will review the key components of carbohydrate vaccines that have remained largely consistent since their inception, and the success of bacterial carbohydrate vaccines. We will then explore the latest developments for both traditional and non-traditional carbohydrate vaccine approaches for three of the world's major protozoan parasitic diseases-malaria, toxoplasmosis, and leishmaniasis. The traditional prophylactic carbohydrate vaccine strategy is being explored for malaria. However, given that parasite disease biology is complex and often arises from host immune responses to parasite antigens, carbohydrate vaccines against deleterious immune responses in host-parasite interactions are also being explored. In particular, the highly abundant glycosylphosphatidylinositol molecules specific for Plasmodium, Toxoplasma, and Leishmania spp. are considered exploitable antigens for this non-traditional vaccine approach. Discussion will revolve around the application of these protozoan carbohydrate antigens for vaccines currently in preclinical development.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Unknown 112 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 16%
Student > Ph. D. Student 17 15%
Student > Bachelor 14 12%
Researcher 11 10%
Student > Doctoral Student 8 7%
Other 17 15%
Unknown 28 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 18%
Biochemistry, Genetics and Molecular Biology 17 15%
Chemistry 17 15%
Immunology and Microbiology 8 7%
Medicine and Dentistry 6 5%
Other 16 14%
Unknown 29 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2023.
All research outputs
#2,611,434
of 25,205,261 outputs
Outputs from Frontiers in Cellular and Infection Microbiology
#486
of 7,935 outputs
Outputs of similar age
#47,344
of 323,441 outputs
Outputs of similar age from Frontiers in Cellular and Infection Microbiology
#19
of 193 outputs
Altmetric has tracked 25,205,261 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,935 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,441 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 193 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.